A Study of MSB0254 Injection in Advanced Solid Tumors

NCT04381325 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Advanced Solid Tumor

Interventions

DRUG: MSB0254 Injection

Sponsor

Suzhou Transcenta Therapeutics Co., Ltd.